A sensitive method for the simultaneous determination of caffeine and its dimethylxanthine metabolites in human plasma: Application to CYP1A2 phenotyping

Journal of Liquid Chromatography and Related Technologies

Volumn 21, Issue 8, 1998, Pages 1161-1171

  Frye, Reginald F ^a   Stiff, Dwight D ^a   Branch, Robert A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; PARAXANTHINE; THEOBROMINE; THEOPHYLLINE; XANTHINE DERIVATIVE;

ARTICLE; CALIBRATION; DRUG BLOOD LEVEL; DRUG DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PHENOTYPE;

EID: 0031802771     PISSN: 10826076     EISSN: None     Source Type: Journal    
DOI: 10.1080/10826079808006591     Document Type: Article

References (28)

1. W. Kalow, B. K. Tang, Clin. Pharmacol. Ther. 53, 503 (1993).
2. U. Fuhr, J. Doehmer, N. Battula, C. Wolfel, C. Kudla, Y. Keita, A. H. Staib, Biochem. Pharmacol. 43, 225 (1992).
3. H. K. Kroemer, J. C. Gautier, P. Beaune, C. Henderson, C. R. Wolf, M. Eichelbaum, Arch. Pharmacol. 348, 332 (1993).
4. T. Shimada, M. Iwasaki, M. V. Martin, F. P. Guengerich, Cancer Res. 49, 3218 (1989).
5. B. P. Murray, R. J. Edwards, S. Murray, A. M. Singleton, D. S. Davies, A. R. Boobis, Carcinogenesis, 14, 585 (1993).
6. T. Shimada, Y. Okuda, Biochem. Pharmacol. 37, 459 (1988).
7. M. A. Butler, M. Iwasaki, F. P. Guengerich, F. F. Kadlubar, Biochemistry, 86, 7696 (1989).
8. L. Gu, F. J. Gonzalez, W. Kalow, B. K. Tang, Pharmacogenetics. 2, 73 (1992).
9. U. Fuhr, K. L. Rost, Pharmacogenetics. 4, 109 (1994).
10. E. Tanaka, A. Ishikawa, Y. Yamamoto, A. Osada, K. Tsuji, K. Fukao, S. Misawa, Y. Iwasaki, Int. J. Clin. Pharmacol. Ther. Toxicol. 30, 336 (1992).
11. P. Parra, A. Limon, S. Ferre, T. Guix and F. Jane, J. Chromatogr. 570, 185 (1991).
12. P. Casoli, H. Verine, Biomed. Chrom. 4, 209 (1990).
13. T. E. Leakey, J. Chromatogr. 507, 199 (1990).
14. K. Matsumoto, H. Kikuchi, H. Iri, H. Takahasi, M. Umino, J. Chromatogr. 425, 323 (1988).
15. E. Naline, B. Flouvat, C. Advenier, M. Pays, J. Chromatogr. 419, 177 (1987).
16. T. Zysset, C. Tlach, J. Pharmacol. Exp. Ther. 240, 271 (1987).
17. C. E. Pickard, A. D. Stewart, R. Hartley, M. D. Lucock, Ann. Clin. Biochem. 23, 440 (1986).
18. R. Hartley, I. J. Smith, J. R. Cookman, J. Chromatogr. 342, 105 (1985).
19. A. Wahllander, E. Renner, G. Karlaganis, J. Chromatogr. 338, 369 (1985).
20. T. Zysset, A. Wahllander, R. Preisig, Ther. Drug Monit. 6, 348 (1984).
21. J. N. Miceli, M. K. Aravind, W. J. Ferrell, Ther. Drug Monit. 6, 344 (1984).
22. B. R. Dorrbecker, S. H. Mercik, P. A. Kramer, J. Chromatogr. 336, 293 (1984).
23. B. Stavric, R. Klassen, S. G. Gilbert, J. Chromatogr. 310, 107 (1984).
24. R. Hartley, J. R. Cookman, I. J. Smith, J. Chromatogr. 306, 191 (1984).
25. N. R. Scott, J. Chakraborty, V. Marks, Ann. Clin. Biochem. 21, 120 (1984).
26. D. D. Breimer, J. H. Schellens, Trends. Pharmacol. Sci. 11, 223 (1990).
27. N. R. Scott, D. Stambuk, J. Chakraborty, V. Marks, M. Y. Morgan, Br. J. Clin. Pharmacol. 27, 205 (1989).
28. E. Tanaka, J. Chromatogr. 575, 311 (1992).